Alpha Genomix Laboratories Revenue and Competitors

Location

N/A

Total Funding

Research

Industry

Estimated Revenue & Valuation

  • Alpha Genomix Laboratories's estimated annual revenue is currently $2.7M per year.(i)
  • Alpha Genomix Laboratories's estimated revenue per employee is $81,600

Employee Data

  • Alpha Genomix Laboratories has 33 Employees.(i)
  • Alpha Genomix Laboratories grew their employee count by -8% last year.

Alpha Genomix Laboratories's People

NameTitleEmail/Phone
1
Territory ManagerReveal Email/Phone
2
Clinical Laboratory SupervisorReveal Email/Phone
3
Clinical Laboratory TechnologistReveal Email/Phone
4
Staff ScientistReveal Email/Phone
5
Medical Laboratory TechnologistReveal Email/Phone
6
Laboratory AssistantReveal Email/Phone
7
Lead Laboratory TechnicianReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$1.1M18-18%N/AN/A
#2
$3.5M4313%N/AN/A
#3
$3.2M390%N/AN/A
#4
$3.5M43N/AN/AN/A
#5
$3.6M445%N/AN/A
#6
$2M288%N/AN/A
#7
$22.8M2032%N/AN/A
#8
$0.2M4N/AN/AN/A
#9
$3.1M389%N/AN/A
#10
$1M17-11%N/AN/A
Add Company

What Is Alpha Genomix Laboratories?

Alpha Genomix is a state-of-the-art molecular diagnostics laboratory dedicated to providing personalized patient care. Using cutting edge tools, our team of highly qualified professionals offer industry leading pharmacogenetic testing (PGT). Motivated by a passion to improve the standard quality of care, we are dedicated to providing accurate, fast, and comprehensive laboratory services. We provide physicians with easy to interpret and actionable genetic reports, allowing them to truly customize a patient’s treatment plan. A partnership with Alpha Genomix means always having the dedicated support of a laboratory that goes above and beyond to satisfy its customers.

keywords:N/A

N/A

Total Funding

33

Number of Employees

$2.7M

Revenue (est)

-8%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$5.4M33-8%N/A
#2
$6.5M336%N/A
#3
$6M3332%N/A
#4
N/A3410%N/A
#5
$7.6M353%N/A